Interferon-γ induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes

Rheumatology

Volumn 42, Issue 3, 2003, Pages 442-445

  Moller B ^a   Paulukat, J ^a   Nold, M ^a   Behrens, M ^a   Kukoc Zivojnov, N ^a   Kaltwasser, J P ^a   Pfeilschifter, J ^a   Muhl H ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Fibroblast; IFN ; IL 18BP; Rheumatoid arthritis; Synoviocyte

Indexed keywords

BINDING PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; ISOPROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DATA ANALYSIS; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MONONUCLEAR CELL; NEGATIVE FEEDBACK; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVIOCYTE; UPREGULATION;

ARTHRITIS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; FIBROBLASTS; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; OSTEOARTHRITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPONDYLARTHROPATHIES; SYNOVIAL MEMBRANE; UP-REGULATION;

EID: 0345268692     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg146     Document Type: Article

References (24)

1. Dinarello CA, Novick D, Puren AJ et al. Overview of interleukin-18: more than an interferon-γ-inducing factor. J Leukoc Biol 1998;63:658-64.
2. Gracie JA, Forsey RJ, Chan WL et al. A proinflammatory role for 1L-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-401.
3. Klimiuk PA, Goronzy JJ, Bjornsson J, Beckenbaugh RD, Weyand CM. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol 1997;151:1311-9.
4. Sebbag M, Parry SL, Brennan FM, Feldmann M. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-α, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis. Eur J Immunol 1997;27:624-32.
5. Ghezzi P, Dinarello CA. IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-γ. J Immunol 1988;140:4238-44.
6. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. Mutual antagonism between interferon-γ and tumor necrosis factor-α on HLA-DR expression, proliferation, collagenase production, and granulocyte-macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990;86:1790-8.
7. Lemmel EM, Brackertz D, Franke M et al. Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-γ. Rheumatol Int 1988;8:87-93.
8. Cannon GW, Pincus SH, Emkey RD et al. Double-blind trial of recombinant γ-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1989;32:964-73.
9. H1 cytokine response. Immunity 1999;10:127-36.
10. Novick D, Schwartsburd B, Pinkus R et al. A novel IL-18bp ELISA shows elevated serum IL-18bp in sepsis and extensive decrease of free IL-18. Cytokine 2001;69:5025-30.
11. Kim SH, Eisenstein M, Reznikov L et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000;97:1190-5.
12. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. Dougados M, van der Linden S, Juhlin R et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
14. Möller B, Kukoc-Zivojnov N, Kessler U et al. Interleukin-18 expression and its monokine directed function in rheumatoid arthritis. Rheumatology 2001;40:302-9.
15. Paulukat J, Bosmann M, Nold M et al. Expression and release of IL-18 binding protein in response to interferon-γ. J Immunol 2001;167:7038-43.
16. Feldmann M, Charles P, Taylor P, Maini RN. Biological insights from clinical trials with anti-TNF therapy. Springer Semin Immunopathol 1998;20:21-8.
17. Jiang Y, Genant HK, Watt I et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum 2000;43:1001-9.
18. Mühl H, Kämpfer H, Bosmann M, Frank S, Radeke H, Pfeilschifter J. Interferon-γ mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun 2000;267:960-3.
19. Corbaz A, ten Hove T, Herren S et al. IL-18-binding protein expression by endothelial cells and macrophages is up regulated during active Crohn's disease. J Immunol 2002;168:3608-16.
20. Puliti M, von Hunolstein C, Bistoni F, Mosci P, Orefici G, Tissi L. Influence of interferon-γ administration on the severity of experimental group B streptococcal arthritis. Arthritis Rheum 2000;43:2678-86.
21. Matthys PK, Vermeire T, Mitera T, Heremans H, Huang S, Billiau A. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-γ receptor-deficient mice. Eur J Immunol 1998;28:2143-51.
22. Kawashima M, Yamamura M, Taniai M et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001;44:550-60.
23. Yamamura M, Kawashima M, Taniai M et al. Interferon-γ-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 2001;44:275-85.
24. Plater-Zyberk C, Joosten LA, Helsen MM et al. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest 2001;108:1825-32.